Skip to main content
Figure 4 | Journal of Hematology & Oncology

Figure 4

From: A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

Figure 4

Comparison of the CR rates of CAG regimen in AML patients according to karyotypes. Summary CR rates of CAG regimen were calculated using the random-effects model. Horizontal lines through the squares represent 95% CIs. The diamonds represent the overall CR event rate from the meta-analyses and the corresponding 95% CIs.

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us